BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 16934070)

  • 1. Outliers in RhD membrane integration are explained by variant RH haplotypes.
    Yu X; Wagner FF; Witter B; Flegel WA
    Transfusion; 2006 Aug; 46(8):1343-51. PubMed ID: 16934070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule.
    Flegel WA; von Zabern I; Doescher A; Wagner FF; Vytisková J; Písacka M
    Transfusion; 2008 Jan; 48(1):25-33. PubMed ID: 17900276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the Rh antigen RH48 (JAL).
    Hustinx H; Poole J; Bugert P; Gowland P; Still F; Fontana S; Scharberg EA; Tilley L; Daniels G; Niederhauser C
    Vox Sang; 2009 Apr; 96(3):234-9. PubMed ID: 19207167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RH hybrid box identification in subjects with Rh negative phenotype from Mexico's Valley].
    Baptista-González HA; Rosenfeld-Mann F; Trueba-Gómez R; Reyes-Maldonado E; Jiménez-Zamudio LA
    Gac Med Mex; 2010; 146(1):19-23. PubMed ID: 20422930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on polymorphism of D gene exons among RhD-negative Chinese Han population].
    Xu Q; Zhang S; Zhang J; Si G; Song Y; Wang M; Li J; Wang W; Nie X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Feb; 18(1):39-42. PubMed ID: 11172641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-frame triplet deletions in RHD alter the D antigen phenotype.
    Flegel WA; Eicher NI; Doescher A; Hustinx H; Gowland P; Mansouri Taleghani B; Petershofen EK; Bauerfeind U; Ernst M; von Zabern I; Schrezenmeier H; Wagner FF
    Transfusion; 2006 Dec; 46(12):2156-61. PubMed ID: 17176329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotype Types and Genetic Mutation Mechanism of Rhesus D Variant Individuals].
    Luo H; Wen JZ; Zhang RQ; Ji YL; Mo CY; Wei L; Wang Z; Liao ZJ; Luo GP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1804-1809. PubMed ID: 29262920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
    Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
    Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai.
    Li Q; Hou L; Guo ZH; Ye LY; Yue DQ; Zhu ZY
    Vox Sang; 2009 Aug; 97(2):139-46. PubMed ID: 19490579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weak D caused by a founder deletion in the RHD gene.
    Fichou Y; Chen JM; Le Maréchal C; Jamet D; Dupont I; Chuteau C; Durousseau C; Loirat MJ; Bailly P; Férec C
    Transfusion; 2012 Nov; 52(11):2348-55. PubMed ID: 22420867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of partial D and weak D: implications for blood bank practice.
    Flegel WA; Wagner FF
    Clin Lab; 2002; 48(1-2):53-9. PubMed ID: 11833677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype.
    Omi T; Takahashi J; Tsudo N; Okuda H; Iwamoto S; Tanaka M; Seno T; Tani Y; Kajii E
    Biochem Biophys Res Commun; 1999 Jan; 254(3):786-94. PubMed ID: 9920819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
    Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
    Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the RhD negative phenotype in Chinese.
    Peng CT; Shih MC; Liu TC; Lin IL; Jaung SJ; Chang JG
    Int J Mol Med; 2003 Apr; 11(4):515-21. PubMed ID: 12632107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification.
    Haer-Wigman L; Veldhuisen B; Jonkers R; Lodén M; Madgett TE; Avent ND; de Haas M; van der Schoot CE
    Transfusion; 2013 Jul; 53(7):1559-74. PubMed ID: 23043317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.